Autologous Platelet-Rich Plasma Eye Drops for the Treatment of Post-LASIK Chronic Ocular Surface Syndrome

Jorge L Alio, Alejandra E Rodriguez, Ahmed A Abdelghany, Renan F Oliveira, Jorge L Alio, Alejandra E Rodriguez, Ahmed A Abdelghany, Renan F Oliveira

Abstract

Purpose: To evaluate the efficacy of autologous platelet-rich plasma (E-PRP) eye drops for the treatment of chronic ocular surface syndrome (OSS) following laser in situ keratomileusis (LASIK).

Methods: This prospective interventional consecutive clinical study include 156 eyes of 80 patients affected by post-LASIK chronic OSS who were treated with autologous E-PRP 6 times a day as monotherapy for 6 weeks.

Results: Dry eye symptoms improved in 85% of the cases. A decrease in at least one quadrant to total disappearance on CFS was observed in 89.6% of the patients who had positive CFS before treatment. Three eyes presented severe punctate keratitis (1.9%) at baseline, all of which healed completely. Conjunctival hyperemia improved in 93.3% of the patients with previous signs of ocular surface inflammation. There was a significant improvement in logMAR CDVA from 0.14 ± 0.19 to 0.06 ± 0.12 (p = 0.000), and 74 (71.4%) eyes improved at least 1 line in CDVA.

Conclusion: Monotherapy with autologous E-PRP is a well-tolerated, safe, and effective treatment for the management of post-LASIK ocular surface syndrome.

Precis: Monotherapy with autologous platelet-rich plasma eye drops has been shown to be an adequate option for the treatment of post-LASIK chronic ocular surface syndrome. This trial is registered with NCT03322917.

Figures

Figure 1
Figure 1
Patient with post-LASIK chronic OSS. (a) Before treatment, positive corneal fluorescein staining showing paracentral diffuse and coalescent areas of punctate keratitis in the inferior quadrant. (b) Transparent cornea, with complete resolution of previous punctate keratitis after treatment with E-PRP.
Figure 2
Figure 2
Visual change after treatment with autologous PRP eye drops in eyes presenting post-LASIK ocular surface syndrome and CDVA ≤ 0.9.

References

    1. Solomon K. D., Fernández de Castro L. E., Sandoval H. P., et al. LASIK world literature review: quality of life and patient satisfaction. Ophthalmology. 2009;116(4):691–701. doi: 10.1016/j.ophtha.2008.12.037.
    1. Nettune G. R., Pflugfelder S. C. Post-LASIK tear dysfunction and dysesthesia. The Ocular Surface. 2010;8(3):135–145. doi: 10.1016/S1542-0124(12)70224-0.
    1. Alio J. L., Pastor S., Ruiz-Colecha J., Rodriguez A., Artola A. Treatment of ocular surface syndrome after LASIK with autologous platelet-rich plasma. Journal of Refractive Surgery. 2007;23(6):617–619.
    1. Wilson S. E., Ambrosio R., Jr. Laser in situ keratomileusis-induced neurotrophic epitheliopathy. American Journal of Ophthalmology. 2001;132(3):405–406. doi: 10.1016/S0002-9394(01)00995-3.
    1. Ambrósio R., Jr., Tervo T., Wilson S. E. LASIK-associated dry eye and neurotrophic epitheliopathy: pathophysiology and strategies for prevention and treatment. Journal of Refractive Surgery. 2008;24(4):396–407.
    1. Toda I. LASIK and the ocular surface. Cornea. 2008;27(Supplement 1):S70–S76. doi: 10.1097/ICO.0b013e31817f42c0.
    1. Albietz J. M., Lenton L. M., Franzco, McLennan S. G. Chronic dry eye and regression after laser in situ keratomileusis for myopia. Journal of Cataract & Refractive Surgery. 2004;30(3):675–684. doi: 10.1016/j.jcrs.2003.07.003.
    1. Bower K. S., Sia R. K., Ryan D. S., Mines M. J., Dartt D. A. Chronic dry eye in photorefractive keratectomy and laser in situ keratomileusis: manifestations, incidence, and predictive factors. Journal of Cataract and Refractive Surgery. 2015;41(12):2624–2634. doi: 10.1016/j.jcrs.2015.06.037.
    1. Shoja M. R., Besharati M. R. Dry eye after LASIK for myopia: incidence and risk factors. European Journal of Ophthalmology. 2007;17(1):1–6.
    1. Chao C., Golebiowski B., Stapleton F. The role of corneal innervation in LASIK-induced neuropathic dry eye. The Ocular Surface. 2014;12(1):32–45. doi: 10.1016/j.jtos.2013.09.001.
    1. Linna T. U., Vesaluoma M. H., Perez-Santonja J. J., Petroll W. M., Alio J. L., Tervo T. M. Effect of myopic LASIK on corneal sensitivity and morphology of subbasal nerves. Investigative Ophthalmology & Visual Science. 2000;41(2):393–397.
    1. Yu E. Y. W., Leung A., Rao S., Lam D. S. C. Effect of laser in situ keratomileusis on tear stability. Ophthalmology. 2000;107(12):2131–2135. doi: 10.1016/s0161-6420(00)00388-2.
    1. Rodriguez-Prats J. L., Hamdi I. M., Rodriguez A. E., Galal A., Alio J. L. Effect of suction ring application during LASIK on goblet cell density. Journal of Refractive Surgery. 2007;23(6):559–562.
    1. Yazawa M., Ogata H., Nakajima T., Mori T., Watanabe N., Handa M. Basic studies on the clinical applications of platelet-rich plasma. Cell Transplantation. 2003;12(5):509–518. doi: 10.3727/000000003108747073.
    1. Tsubota K., Goto E., Fujita H., et al. Treatment of dry eye by autologous serum application in Sjögren’s syndrome. British Journal of Ophthalmology. 1999;83(4):390–395. doi: 10.1136/bjo.83.4.390.
    1. Noda-Tsuruya T., Asano-Kato N., Toda I., Tsubota K. Autologous serum eye drops for dry eye after LASIK. Journal of Refractive Surgery. 2006;22(1):61–66.
    1. Alio J. L., Rodriguez A. E., WróbelDudzińska D. Eye platelet-rich plasma in the treatment of ocular surface disorders. Current Opinion in Ophthalmology. 2015;26(4):325–332. doi: 10.1097/ICU.0000000000000169.
    1. Alio J. L., Arnalich-Montiel F., Rodriguez A. E. The role of “eye platelet rich plasma” (E-PRP) for wound healing in ophthalmology. Current Pharmaceutical Biotechnology. 2012;13(7):1257–1265. doi: 10.2174/138920112800624355.
    1. Alio J. L., Abad M., Artola A., Rodriguez-Prats J. L., Pastor S., Ruiz-Colecha J. Use of autologous platelet-rich plasma in the treatment of dormant corneal ulcers. Ophthalmology. 2007;114(7):1286–1293.e1. doi: 10.1016/j.ophtha.2006.10.044.
    1. Alio J. L., Colecha J. R., Pastor S., Rodriguez A., Artola A. Symptomatic dry eye treatment with autologous platelet-rich plasma. Ophthalmic Research. 2007;39(3):124–129. doi: 10.1159/000100933.
    1. Javaloy J., Alió J. L., Rodriguez A. E., Vega A., Muñoz G. Effect of platelet-rich plasma in nerve regeneration after LASIK. Journal of Refractive Surgery. 2013;29(3):213–219. doi: 10.3928/1081597X-20130129-04.
    1. Ortuno-Prados V. J., Alio J. L. Treatment of a neurotrophic corneal ulcer with solid platelet-rich plasma and Tutopatch®. Archivos de la Sociedad Española de Oftalmología. 2011;86(4):121–123. doi: 10.1016/S2173-5794(11)70023-8.
    1. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007) The Ocular Surface. 2007;5(2):75–92. doi: 10.1016/s1542-0124(12)70081-2.
    1. Lemp M. A., Baudouin C., Amrane M., Ismail D., Garrigue J. S., Buggage R. R. Poor correlation between dry eye disease (DED) signs and symptoms in a phase III randomized clinical trial. Investigative Ophthalmology & Visual Science. 2011;52:p. 3821.
    1. Baudouin C., Aragona P., Van Setten G., et al. Diagnosing the severity of dry eye: a clear and practical algorithm. British Journal of Ophthalmology. 2014;98(9):1168–1176. doi: 10.1136/bjophthalmol-2013-304619.
    1. Belmonte C., Carmen Acosta M., Gallar J. Neural basis of sensation in intact and injured corneas. Experimental Eye Research. 2004;78(3):513–525. doi: 10.1016/j.exer.2003.09.023.
    1. The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye WorkShop (2007) The Ocular Surface. 2007;5(2):93–107. doi: 10.1016/S1542-0124(12)70082-4.
    1. Chao C., Golebiowski B., Zhao X., Chen S., Zhou S., Stapleton F. Long-term effects of LASIK on corneal innervation and tear neuropeptides and the associations with dry eye. Journal of Refractive Surgery. 2016;32(8):518–524. doi: 10.3928/1081597X-20160603-01.
    1. Battat L., Macri A., Dursun D., Pflugfelder S. C. Effects of laser in situ keratomileusis on tear production, clearance, and the ocular surface. Ophthalmology. 2001;108(7):1230–1235. doi: 10.1016/S0161-6420(01)00623-6.
    1. De Paiva C. S., Chen Z., Koch D. D. The incidence and risk factors for developing dry eye after myopic LASIK. American Journal of Ophthalmology. 2006;141(3):438–445. doi: 10.1016/j.ajo.2005.10.006.
    1. Donnenfeld E. D., Solomon K., Perry H. D., et al. The effect of hinge position on corneal sensation and dry eye after LASIK. Ophthalmology. 2003;110(5):1023–1029. doi: 10.1016/S0161-6420(03)00100-3.
    1. Toda I., Asano-Kato N., Komai-Hori Y., Tsubota K. Dry eye after laser in situ keratomileusis. American Journal of Ophthalmology. 2001;132(1):1–7. doi: 10.1016/S0002-9394(01)00959-X.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit